GlaxoSmithKline PLC (GSK) announces partnership to develop therapeutics to treat FSHD. The goal of the new agreement is to develop a small-molecule-based medicine to potentially reverse FSHD
GlaxoSmithKline PLC (GSK) announces partnership to develop therapeutics to treat FSHD
Year-End Challenge to Fund the Treatment for FSHD!
Year-End Challenge to Fund the Treatment for FSHD! A group of long-time supporters have come forward to challenge the Society’s members and friends to make gifts to Fund the Treatment for FSHD. These generous donors will match your gift dollar for dollar, up to a total of $255,000, if you make your gift by December… Read More »